Cas No.: | 846589-98-8 |
Chemical Name: | Lorcaserin Hydrochloride (>50% ee) |
Synonyms: | (R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine hydrochloride;(R)-1H-3-BENZAZEPINE,8-CHLORO-2,3,4,5-TETRAHYDRO-1-METHYL-,HYDROCHLORIDE;LORCASERIN HCL;(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride;(1R)-8-chloro-1-Methyl-2,3,4,5-tetrahydro-1H-3-benzazepine;Lorcaserin (hydrochloride);LORCASERIN HYDROCHLORIDE;APD356;APD-356;LORERIN HCL;Lorerin hydrochloride;(R)-1H-3-BENZAZEPINE;Belviq;Lorqess;Belviq Xr;0QJF08GDPE;Lorcaserin hydrochloride [USAN];Belviq (TN);Lorcaserin hydrochloride (USAN);APD 356;R-Lorcaserin hydrochloride;Lorcaserin hydrochloride;lorcaserin hydrochloride (APD-356);R Lorcaserin hydrochloride;Green Card mianserin hydrochloride;1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-methyl-, hydrochloride, (1R)- (9CI);(R)-Lorcaserin hydrochloride;Lorcaserin hydrochloride |
SMILES: | C[C@H]1CNCCC2C=CC(=CC1=2)Cl.Cl |
Formula: | C11H15Cl2N |
M.Wt: | 232.149501085281 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | Lorcaserin (APD-356, trade name upon approval Belviq,expected trade name during development, Lorqess is a weight-loss drug developed by Arena Pharmaceuticals. It has serotonergic properties and acts as an anorectic. For the detailed information about the solubility of Lorcaserin in water, the solubility of Lorcaserin in DMSO, the solubility of Lorcaserin in PBS buffer, the animal experiment(test) of Lorcaserin,the in vivo,in vitro and clinical trial test of Lorcaserin,the cell experiment(test) of Lorcaserin,the IC50, EC50 and Affinity of Lorcaserin, please contact DC Chemicals. |